1-4 of 4
Quanyi Lu, MD
Close
Sort by
Journal Articles

Pegylated Recombinant Human Arginase, Rharg-Peg 5,000MW, Targets Cell Cycle Machinery in Multiple Myeloma Cells.

Delong Liu, MD, PhD, Xianghua Lin, MD,PHD, Quanyi Lu, MD,PHD, Thomas Leung, Paul N.M. Cheng, MD, Jen-Wei Chiao, PHD
Journal: Blood
Blood (2007) 110 (11): 4095.
https://doi.org/10.1182/blood.V110.11.4095.4095
Published: 2007
Journal Articles

Haplo-Identical Allogeneic Stem Cell Transplantation Using GCSF-Mobilized Marrow Plus Blood Stem Cells from Parent Donors for Children with High-Risk Leukemia.

Quanyi Lu, MD, PhD, Xiaoqing Niu, MD, Peng Zhang, MD, Delong Liu, MD, PHD
Journal: Blood
Blood (2007) 110 (11): 5084.
https://doi.org/10.1182/blood.V110.11.5084.5084
Published: 2007
Journal Articles

Phenyhexyl Isothiocyanate, a Novel Inhibitor of Histone Deacetylation and Methylation, Induce Growth Arrest and Apoptosis of Myeloma Cells.

Quanyi Lu, MD, PhD, Jane Feng, MD, Karen Seiter, MD, Tauseef Ahmed, MD, Dicky J.W. Chiao, PhD, Delong Liu, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5033.
https://doi.org/10.1182/blood.V108.11.5033.5033
Published: 2006
Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation for a Case of Refractory Systemic Lupus Erythematosus.

Quanyi Lu, MD, Xiaoqing Niu, MD, Yong Guo, MD, Lulu Lu, MD, Delong Liu, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5411.
https://doi.org/10.1182/blood.V106.11.5411.5411
Published: 2005